Among patients with HCC in cohorts 1 and 2, those without UBR5 amplification showed significantly better survival outcomes than those with UBR5 amplification (Fig. 1F and G), indicating that copy numbers contribute to high UBR5 expression and poor survival outcomes in patients with HCC. The gene discussed is UBR5; the disease is hepatocellular carcinoma.